Clinical Trial Update: Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches [Phase 3]

View source ↗

Summary

A multi-center Phase 3 randomized controlled trial is evaluating intravenous ketamine for efficacy and safety in chronic daily headaches and is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Daily Headache

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Chronic Daily Headache | Phase 3 | Status: RECRUITING